RTI Biologics Announces 2012 Fourth Quarter, Full Year Results, 2013 Financial Guidance
2/7/2013 6:20:28 AM
RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year of 2012 as follows:
• Achieved quarterly revenues of $44.6 million, a 4 percent increase over the fourth quarter of 2011.
comments powered by